63 Recruiting Studies Using Tocilizumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Tocilizumab
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
📍 Johns Hopkins — Baltimore, Maryland
Immune-related Adverse Events
View Study & Checklist ➔A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Cancer Center — Duarte, California
Non-Hodgkin Lymphoma
View Study & Checklist ➔A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
📍 Infirmary Cancer Care — Mobile, Alabama
Non-Hodgkin Lymphoma
View Study & Checklist ➔Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
📍 M D Anderson Cancer Center — Houston, Texas
Clinical Stage III Cutaneous Melanoma AJCC v8
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Lymphoma
View Study & Checklist ➔Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
📍 University of San Francisco, California — San Francisco, California
Cancer
View Study & Checklist ➔A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
📍 The Angeles Clinic — Los Angeles, California
Melanoma
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
📍 University of Alabama at Birmingham School of Medicine — Birmingham, Alabama
B-cell Non-Hodgkin Lymphoma
View Study & Checklist ➔In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
📍 Los Angeles General Medical Center — Los Angeles, California
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
📍 Weill Cornell Medical College — New York, New York
Hematologic Malignancy
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
📍 City of Hope National Medical Center — Duarte, California
Follicular Lymphoma
View Study & Checklist ➔Tocilizumab Treatment in Patients With COVID-19
📍 National Cancer Institute of Mexico — Mexico City, Mexico City
Sars-CoV2
View Study & Checklist ➔Tocilizumab in Children With ACP
📍 Children's Hospital Colorado — Aurora, Colorado
Adamantinomatous Craniopharyngioma
View Study & Checklist ➔A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
📍 Clinica De La Costa — Barranquilla,
Systemic Lupus Erythematosus
View Study & Checklist ➔A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
📍 University of Michigan — Ann Arbor, Michigan
Non-Hodgkin's Lymphoma
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
📍 University of Colorado — Aurora, Colorado
Multiple Myeloma
View Study & Checklist ➔A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Medical Center — Pasadena, California
Lymphoma, Non-Hodgkin
View Study & Checklist ➔A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
📍 Yale University — New Haven, Connecticut
Solid Tumors
View Study & Checklist ➔Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
CD19 Positive
View Study & Checklist ➔Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
📍 Kaiser Permanente-Anaheim — Anaheim, California
Diffuse Astrocytoma, IDH-Wildtype
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
📍 UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program — San Francisco, California
Non-Hodgkin Lymphoma
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Lymphoma
View Study & Checklist ➔A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
📍 Local Institution - 0035 — Aurora, Colorado
Systemic Lupus Erythematosus
View Study & Checklist ➔Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
Recurrent Plasma Cell Myeloma
View Study & Checklist ➔A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
📍 Instituto CAICI SRL — Rosario,
Systemic Juvenile Idiopathic Arthritis
View Study & Checklist ➔Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
📍 Tufts Medical Center — Boston, Massachusetts
Arthritis, Rheumatoid
View Study & Checklist ➔COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
📍 Barrow Institute — Phoenix, Arizona
New Onset Refractory Status Epilepticus
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
📍 Local Institution - 0035 — Scottsdale, Arizona
Systemic Sclerosis
View Study & Checklist ➔Anti-Interleukin-6 (IL6) in Calciphylaxis
📍 Boston Medical Center — Boston, Massachusetts
Calciphylaxis
View Study & Checklist ➔A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
📍 UT Southwestern — Dallas, Texas
AQP4+ NMOSD
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
📍 UC Irvine Medical Center — Costa Mesa, California
Advanced Liver Cancers
View Study & Checklist ➔Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
📍 Phoenix Children's Hospital /ID# 253403 — Phoenix, Arizona
Juvenile Idiopathic Arthritis
View Study & Checklist ➔Plan Development for Giving Teclistamab in the Outpatient Setting
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Multiple Myeloma
View Study & Checklist ➔A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
📍 Alta Bates Summit Medical Center — Berkeley, California
Lymphoma
View Study & Checklist ➔SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
📍 Emory University — Atlanta, Georgia
Metastatic Breast Cancer
View Study & Checklist ➔An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Relapsing Polychondritis
View Study & Checklist ➔Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
📍 University of Florida — Jacksonville, Florida
Community-acquired Pneumonia, Influenza, COVID-19
View Study & Checklist ➔A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
📍 Colorado Blood Cancer Institute — Denver, Colorado
Multiple Myeloma (MM)
View Study & Checklist ➔A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
📍 Brigham And Womens Hospital — Boston, Massachusetts
Refractory Autoimmune Diseases
View Study & Checklist ➔A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
📍 Mayo Clinic Rochester — Rochester, Minnesota
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
View Study & Checklist ➔A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Mature B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Tocilizumab in Lung Transplantation
📍 St. Joseph's Hospital and Medical Center (Site #: 71192) — Phoenix, Arizona
Lung Transplant
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
📍 City of Hope — Duarte, California
Multiple Myeloma
View Study & Checklist ➔Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Lung Cancer, Nonsmall Cell
View Study & Checklist ➔Tocilizumab for Acute Chest Syndrome
📍 University of Chicago — Chicago, Illinois
Sickle Cell Disease
View Study & Checklist ➔Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
📍 University of Alabama_6th Ave — Birmingham, Alabama
Recurrent Ovarian Cancer
View Study & Checklist ➔TCR1188-ABC Cells in KRAS-mutated Cancers
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Cholangiocarcinoma
View Study & Checklist ➔ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
📍 Children's Hospital Colorado — Aurora, Colorado
Adamantinomatous Craniopharyngioma
View Study & Checklist ➔A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
📍 Beverly Hills Cancer Center (BHCC) — Beverly Hills, California
Multiple Myeloma
View Study & Checklist ➔Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
📍 Emory University School of Medicine: Division of Rheumatology — Atlanta, Georgia
Giant Cell Arteritis (GCA)
View Study & Checklist ➔Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
📍 Winship Cancer Institute at Emory University — Atlanta, Georgia
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
📍 University of California, San Francisco — San Francisco, California
Prostate Adenocarcinoma
View Study & Checklist ➔Neutralizing Interleukin (IL)-6
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Major Depressive Disorder
View Study & Checklist ➔Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
📍 University of California San Francisco Pediatric Rheumatology — San Francisco, California
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
View Study & Checklist ➔Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
📍 University of California-San Diego Medical Center — La Jolla, California
Lactating Women on Select DOI
View Study & Checklist ➔Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
📍 Allegheny Health Network Cancer Institute — Pittsburgh, Pennsylvania
Malignant Pleural Effusion
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
📍 City of Hope — Duarte, California
Metastatic Breast Cancer
View Study & Checklist ➔Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
📍 Arizona Oncology Associates — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
📍 Berenson Cancer Center — Los Angeles, California
Relapsed/Refractory Multiple Myeloma (RRMM)
View Study & Checklist ➔Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
📍 Toronto General Hospital — Toronto, Ontario
Acute Hypoxemic Respiratory Failure
View Study & Checklist ➔Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
📍 University of Florida Health (UF Health) — Gainesville, Florida
Aneurysmal Subarachnoid Hemorrhage
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔